Correlation Between Sino Biopharmaceutica and Genscript Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sino Biopharmaceutica and Genscript Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sino Biopharmaceutica and Genscript Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sino Biopharmaceutical Ltd and Genscript Biotech, you can compare the effects of market volatilities on Sino Biopharmaceutica and Genscript Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sino Biopharmaceutica with a short position of Genscript Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sino Biopharmaceutica and Genscript Biotech.

Diversification Opportunities for Sino Biopharmaceutica and Genscript Biotech

-0.11
  Correlation Coefficient

Good diversification

The 3 months correlation between Sino and Genscript is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Sino Biopharmaceutical Ltd and Genscript Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genscript Biotech and Sino Biopharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sino Biopharmaceutical Ltd are associated (or correlated) with Genscript Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genscript Biotech has no effect on the direction of Sino Biopharmaceutica i.e., Sino Biopharmaceutica and Genscript Biotech go up and down completely randomly.

Pair Corralation between Sino Biopharmaceutica and Genscript Biotech

Assuming the 90 days horizon Sino Biopharmaceutical Ltd is expected to generate 1.29 times more return on investment than Genscript Biotech. However, Sino Biopharmaceutica is 1.29 times more volatile than Genscript Biotech. It trades about 0.08 of its potential returns per unit of risk. Genscript Biotech is currently generating about -0.08 per unit of risk. If you would invest  800.00  in Sino Biopharmaceutical Ltd on September 17, 2024 and sell it today you would earn a total of  105.00  from holding Sino Biopharmaceutical Ltd or generate 13.13% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Sino Biopharmaceutical Ltd  vs.  Genscript Biotech

 Performance 
       Timeline  
Sino Biopharmaceutical 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Sino Biopharmaceutical Ltd are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile primary indicators, Sino Biopharmaceutica showed solid returns over the last few months and may actually be approaching a breakup point.
Genscript Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Genscript Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Sino Biopharmaceutica and Genscript Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sino Biopharmaceutica and Genscript Biotech

The main advantage of trading using opposite Sino Biopharmaceutica and Genscript Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sino Biopharmaceutica position performs unexpectedly, Genscript Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genscript Biotech will offset losses from the drop in Genscript Biotech's long position.
The idea behind Sino Biopharmaceutical Ltd and Genscript Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities